Literature DB >> 30430549

Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.

C Marasca1, A Masarà1, M C Annunziata1, V Bettoli2, M A Luciano1, G Fabbrocini1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30430549     DOI： 10.1111/bjd.17423

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome.

Authors:  Orlando Zagaria; Angelo Ruggiero; Gabriella Fabbrocini; Lucia Gallo; Marco Romanelli; Claudio Marasca
Journal:  Int Wound J       Date:  2020-05-22       Impact factor: 3.315

2.  Hidradenitis Suppurativa in a Patient Affected by Mayer-Rokitansky-Küster-Hauser Syndrome: Insight into the Role of Hormones in HS.

Authors:  Angelo Ruggiero; Gabriella Fabbrocini; Matteo Megna; Giuseppe Monfrecola; Claudio Marasca
Journal:  Skin Appendage Disord       Date:  2020-10-19

Review 3.  [Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].

Authors:  P Cramer; S Schneider-Burrus; M Kovács; L Scholl; M Podda; F G Bechara
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.